Page 776 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

754 PART IV Specific Malignancies in the Small Animal Patient

79. Schick RO, Murphy GF, Goldschmidt MH: Cutaneous lympho- 102. Valli VE, Vernau W, de Lorimier LP, et al.: Canine indolent nodular
sarcoma and leukemia in a cat, J Am Vet Med Assoc 203:1155–1158, lymphoma, Vet Pathol 43:241–256, 2006.
1993. 103. National Cancer Institute sponsored study of classifications of
VetBooks.ir 80. Thrall MA, Macy DW, Snyder SP, et al.: Cutaneous lymphosar- non-Hodgkin’s lymphomas: summary and description of a work-
ing formulation for clinical usage. The Non-Hodgkin’s Lymphoma
coma and leukemia in a dog resembling Sezary syndrome in man,
Vet Pathol 21:182–186, 1984.
Pathologic Classification Project, Cancer 49:2112–2135, 1982.
81. Keller SM, Vernau W, Hodges J, et al.: Hepatosplenic and hepato- 104. Lennert KFA: Histopathology of non-hodgkin’s lymphomas (based on
cytotropic T-cell lymphoma: two distinct types of T-cell lymphoma the updated kiel classification), ed 2, Berlin, 1990, Springer-Verlag.
in dogs, Vet Pathol 50:281–290, 2013. 105. Carter RF, Valli VE, Lumsden JH: The cytology, histology and
82. Cienava EA, Barnhart KF, Brown R, et al.: Morphologic, immu- prevalence of cell types in canine lymphoma classified according to
nohistochemical, and molecular characterization of hepatosplenic the National Cancer Institute Working Formulation, Can J Vet Res
T-cell lymphoma in a dog, Vet Clin Pathol 33:105–110, 2004. 50:154–164, 1986.
83. Fry MM, Vernau W, Pesavento PA, et al.: Hepatosplenic lym- 106. Bromberek JL, Rout ED, Agnew MR, et al.: Breed distribution and
phoma in a dog, Vet Pathol 40:556–562, 2003. clinical characteristics of b cell chronic lymphocytic leukemia in
84. Dargent FJ, Fox LE, Anderson WI: Neoplastic angioendothelioma- dogs, J Vet Intern Med 30:215–222, 2016.
tosis in a dog: an angiotropic lymphoma, Cornell Vet 78:253–262, 107. Hughes KL, Labadie JD, Yoshimoto JA, et al.: Increased frequency
1988. of CD45 negative T cells (T zone cells) in older Golden retriever
85. McDonough SP, Van Winkle TJ, Valentine BA, et al.: Clinicopath- dogs, Vet Comp Oncol 16:E109–E116, 2018.
ological and immunophenotypical features of canine intravascular 108. Cozzi M, Marconato L, Martini V, et al.: Canine nodal marginal
lymphoma (malignant angioendotheliomatosis), J Comp Pathol zone lymphoma: descriptive insight into the biological behaviour,
126:277–288, 2002. Vet Comp Oncol 16:246–252, 2018.
86. Ridge L, Swinney G: Angiotrophic intravascular lymphosarcoma 109. Mizutani N, Goto-Koshino Y, Takahashi M, et al.: Clinical and
presenting as bi-cavity effusion in a dog, Aust Vet J 82:616–618, histopathological evaluation of 16 dogs with T-zone lymphoma,
2004. J Vet Med Sci 78:1237–1244, 2016.
87. Bush WW, Throop JL, McManus PM, et al.: Intravascular lym- 110. Moore AS: Treatment of T cell lymphoma in dogs, Vet Rec 179:277,
phoma involving the central and peripheral nervous systems in a 2016.
dog, J Am Anim Hosp Assoc 39:90–96, 2003. 111. Sayag D, Fournel-Fleury C, Ponce F: Prognostic significance of
88. Cullen CL, Caswell JL, Grahn BH: Intravascular lymphoma pre- morphotypes in canine lymphomas: a systematic review of litera-
senting as bilateral panophthalmitis and retinal detachment in a ture, Vet Comp Oncol 16:12–19, 2018.
dog, J Am Anim Hosp Assoc 36:337–342, 2000. 112. Teske E, van Heerde P, Rutteman GR, et al.: Prognostic factors
89. Summers BA, deLahunta A: Cerebral angioendotheliomatosis in a for treatment of malignant lymphoma in dogs, J Am Vet Med Assoc
dog, Acta Neuropathol 68:10–14, 1985. 205:1722–1728, 1994.
90. Valli VE, Kass PH, San Myint M, et al.: Canine lymphomas: asso- 113. Appelbaum FR, Sale GE, Storb R, et al.: Phenotyping of canine
ciation of classification type, disease stage, tumor subtype, mitotic lymphoma with monoclonal antibodies directed at cell surface anti-
rate, and treatment with survival, Vet Pathol 50:738–748, 2013. gens: classification, morphology, clinical presentation and response
91. Berry CR, Moore PF, Thomas WP, et al.: Pulmonary lymphoma- to chemotherapy, Hematol Oncol 2:151–168, 1984.
toid granulomatosis in seven dogs (1976-1987), J Vet Intern Med 114. Rosol TJ, Capen CC: Mechanisms of cancer-induced hypercalce-
4:157–166, 1990. mia, Lab Invest 67:680–702, 1992.
92. Hatoya S, Kumagai D, Takeda S, et al.: Successful management 115. Weir ECGP, Matus R, et al.: Hypercalcemia in canine lymphosar-
with CHOP for pulmonary lymphomatoid granulomatosis in a coma is associated with the T cell subtype and with secretion of a
dog, J Vet Med Sci 73:527–530, 2011. PTH-like factor, J Bone Miner Res 3, 1988.
93. Park HM, Hwang DN, Kang BT, et al.: Pulmonary lymphomatoid 116. Greenlee PG, Filippa DA, Quimby FW, et al.: Lymphomas in dogs.
granulomatosis in a dog: evidence of immunophenotypic diversity A morphologic, immunologic, and clinical study, Cancer 66:480–
and relationship to human pulmonary lymphomatoid granuloma- 490, 1990.
tosis and pulmonary Hodgkin’s disease, Vet Pathol 44:921–923, 117. Fournel-Fleury C, Ponce F, Felman P, et al.: Canine T-cell lympho-
2007. mas: a morphological, immunological, and clinical study of 46 new
94. Fitzgerald SD, Wolf DC, Carlton WW: Eight cases of canine lym- cases, Vet Pathol 39:92–109, 2002.
phomatoid granulomatosis, Vet Pathol 28:241–245, 1991. 118. Wilkerson MJ, Dolce K, Koopman T, et al.: Lineage differentia-
95. Ponce F, Marchal T, Magnol JP, et al.: A morphological study of tion of canine lymphoma/leukemias and aberrant expression of CD
608 cases of canine malignant lymphoma in France with a focus molecules, Vet Immunol Immunopathol 106:179–196, 2005.
on comparative similarities between canine and human lymphoma 119. Day MJ: Immunophenotypic characterization of cutaneous lym-
morphology, Vet Pathol 47:414–433, 2010. phoid neoplasia in the dog and cat, J Comp Pathol 112:79–96,
96. Seelig DM, Avery AC, Ehrhart EJ, et al.: The comparative diagnos- 1995.
tic features of canine and human lymphoma, Vet Sci 3:11, 2016. 120. Barber LG, Weishaar KM: Criteria for designation of clinical sub-
97. Burkhard MJ, Bienzle D: Making sense of lymphoma diagnos- stage in canine lymphoma: a survey of veterinary oncologists, Vet
tics in small animal patients, Vet Clin North Am Small Anim Pract Comp Oncol 14(Suppl 1):32–39, 2016.
43:1331–1347, vii, 2013. 121. Blackwood L, Sullivan M, Lawson H: Radiographic abnormali-
98. Vezzali E, Parodi AL, Marcato PS, et al.: Histopathologic classifi- ties in canine multicentric lymphoma: a review of 84 cases, J Small
cation of 171 cases of canine and feline non-Hodgkin lymphoma Anim Pract 38:62–69, 1997.
according to the WHO, Vet Comp Oncol 8:38–49, 2010. 122. Starrak GS, Berry CR, Page RL, et al.: Correlation between thoracic
99. Valli VE, San Myint M, Barthel A, et al.: Classification of canine radiographic changes and remission/survival duration in 270 dogs
malignant lymphomas according to the World Health Organiza- with lymphosarcoma, Vet Radiol Ultrasound 38:411–418, 1997.
tion criteria, Vet Pathol 48:198–211, 2011. 123. Congress ‘99: what’s new in the treatment of lymphoma? J Small
100. Stefanello D, Valenti P, Zini E, et al.: Splenic marginal zone lym- Anim Pract 40:51, 1999.
phoma in 5 dogs (2001-2008), J Vet Intern Med 25:90–93, 2011. 124. Yohn SE, Hawkins EC, Morrison WB, et al.: Confirmation of a
101. Flood-Knapik KE, Durham AC, Gregor TP, et al.: Clinical, histo- pulmonary component of multicentric lymphosarcoma with bron-
pathological and immunohistochemical characterization of canine choalveolar lavage in two dogs, J Am Vet Med Assoc 204:97–101,
indolent lymphoma, Vet Comp Oncol 11:272–286, 2013. 1994.